Journal of Pediatric and Adolescent Gynecology
Volume 21, Issue 3 , Pages 135-143 , June 2008

Update on Infectious Diseases in Adolescent Gynecology

  • Teresa Erb, MD
    • ,
  • Richard H. Beigi, MD, MSc

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Richard H. Beigi, MD, Department of Obstetrics, Gynecology & Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh Medical Center, 300 Halket Street, Pittsburgh, PA 15213

References 

  1. Centers for Disease Control and Prevention . Sexually Transmitted Diseases Treatment Guidelines. Morbidity and Mortality Weekly Report. 2006;55:1
  2. Committee on Adolescents (Committee Opinion) . Sexually transmitted diseases. Pediatrics. 1994;94:568
  3. Sweet R. Pelvic Inflammatory Disease, (4th ed.). Infectious diseases of the female reproductive tract. Philadelphia: Williams and Wilkins; 2001;pp 368–412
  4. Martin D. Chlamydial Infection. Med Clin North Am. 1990;74:1367
  5. Weinstock H, Dean D, Bolan G. Chlamydial trachomatis infections. Infect Dis Clin North Am. 1994;8:797
  6. Stamm W, Jones R, Batteiger B. Chlamydia trachomatis (trachoma, perianal infections, lymphogranuloma venereum, and other genital infections). Principles and practices of infectious diseases. 6th ed.. Philadelphia: Elsevier Churchill-Livingston; 2005;pp 2239–2255
  7. Stamm W. Diagnosis of chlamydia trachomatis genitourinary infections. Ann Int Med. 1988;108:710
  8. McCutchan J. Epidemiology of venereal urethritis: Comparison of gonorrhea and nongonococcal urethritis. Rev Infec Dis. 1984;6:669
  9. Black C, Marrazzo J, Johnson RE, et al. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J. Clin Micro. 2002;40:3757
  10. Gaydos C, Chernesky K, Howell M. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis. 1998;177:417
  11. Kousmans E, Johnson RE, Knapp JS, et al. Laboratory testing for Neisseria gonorrheae by recently introduced nonculture tests: A performance review with clinical and public health considerations. Clin Infect Dis. 1998;27:1171
  12. Lau C-Y, Qureshi A. Azithromycin versus doxycycline for genital chlamydial infections: A meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497
  13. Handsfield H, Lipman T, Harnisch J. Asymptomatic gonorrhea in men. N Engl J Med. 1974;290:117
  14. McCormack W, Stumacher RJ, Johnson K, et al. Clinical spectrum of gonococcal infection in women. Lancet. 1977;1:1182
  15. Lyss S, Kamb ML, Peterman TA, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted clinics in the United States. Ann Int Med. 2003;139:178
  16. Jephcot A. Microbiological diagnosis of gonorrhea. Genitourin Med. 1997;73:404
  17. Martin I, Ison CA, Aanensen DM, et al. Changing epidemic profile of quinolone-resistant Neisseriea gonorrhoeae in London. J Infect Dis. 2005;192:1191
  18. Moran J, Levine W. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis. 1995;20(Suppl):S47
  19. Beigi R, Wiesenfeld H. Pelvic inflammatory disease: New diagnostic criteria and treatment. Obstet Gynecol Clin N Am. 2003;30:777
  20. Hillier S, Kiviat N, Hawes S. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol. 1996;175:435
  21. Bongard F, Landers D, Lewis F. Differential diagnosis of appendicitis and pelvic inflammatory disease. Am J Surg. 1985;150:90
  22. Wiesenfeld H, Hillier S, Krohn M. Lower genital tract infection and endometritis: Insight into subclinical pelvic inflammatory disease. Obstet Gynecol. 2002;100:456
  23. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility: A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19:185
  24. Safrin S, Schachter J, Dahrouge D, et al. Long-term sequelae of acute pelvic inflammatory disease: A retrospective cohort study. Am J Obstet Gynecol. 1992;166:1300
  25. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility . Serologic relationship to post chlamydial and gonococcal infection. Sex Transm Dis. 1995;22:71
  26. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980;138:880
  27. Westrom L. Sexually transmitted diseases and infertility. Sex Transm Dis. 1994;21(Suppl):S32
  28. Thomas J, Weiner DH, Earp JA, et al. Frequent reinfection in a community with hyperendemic gonorrhea and chlamydia. Int J STD. 2000;11:461
  29. Holmes K, Levine R, Weaver M. Effectiveness of condom use in preventing sexually transmitted infections. WHO. 2004;82:454
  30. Ness R, Randall H, Richter H. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004;94:1327
  31. Scholes D, Stergachis A, Heidrich F. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362
  32. Golden M, Whittington W, Hansfield H. Effect of expedited treatment of sex partners or recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352:676
  33. Kissinger P, Mohammed H, Richardson-Alston G. Patient-delivered partner treatment for male urethritis: A randomized, controlled trial. Clin Infect Dis. 2005;41:623
  34. Schillinger J, Kissinger P, Calvet H. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis. 2003;30:49
  35. Cates W. Estimates on the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association panel. Sex Transm Dis. 1999;26(4 suppl):S2
  36. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6
  37. Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;(S1):1
  38. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218
  39. Brown DR, Shew ML, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191:181
  40. Centers for Disease Control and Prevention. Genital HPV Infection – CDC Fact Sheet. Centers for Disease Control and Prevention, 2004.
  41. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community: incidence and clinical picture. Acta Obstet Gynecol Scand. 1996;75:287
  42. Von Krogh G. Management of anogenital warts (condyloma acuminata). Eur J Dermatol. 2001;11:598
  43. Wright TC, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. American Society for Colposcopy and Cervical Pathology. Am J Obstet Gynecol. 2003;189:295
  44. Wright TC, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120
  45. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271
  46. Villa LL, Costa RLR, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 LI virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 2006;95:1459
  47. Friedman LS, Kahn J, Middleman AB, et al. Human papillomavirus (HPV) vaccine: A position statement of the Society for Adolescent Medicine. J Adolesc Health. 2006;39:620
  48. Olshen E, Woods ER, Austin B, et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37:248
  49. Brabin L, Roberts SA, Farzaneh F, et al. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine. 2006;24:3087
  50. Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics. 2006;117:1486
  51. Centers for Disease Control and Prevention . Preventing Tetanus, Diphtheria, and Pertussis among Adolescents: Use of a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines (Tdap): Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(RR03):1
  52. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source?. Pediatr Infect Dis J. 2004;23:985
  53. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174
  54. Centers for Disease Control and Prevention . Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2005;54(RR7):1
  55. Bruce MG, Rosenstein NE, Capparella JM, et al. Risk factors for meningococcal disease in college students. JAMA. 2001;286:688
  56. Harrison LH, Dwyer DM, Maples CT, et al. Risk of meningococcal infection in college students. JAMA. 1999;281:1906

PII: S1083-3188(07)00124-6

doi: 10.1016/j.jpag.2007.03.088

Journal of Pediatric and Adolescent Gynecology
Volume 21, Issue 3 , Pages 135-143 , June 2008

Article Tools